Future scenarios

Although the United States will hold its lead in medical technology innovation, the country will continue to lose ground during the next decade. The Innovation Scorecard projects declines for the United States, Japan, Israel, France, the United Kingdom, and Germany.

China, India, and Brazil will experience the strongest gains during the next 10 years. They are quickly taking the lead in developing lean, frugal, and reverse innovation that will enable them to leapfrog developed countries in innovative healthcare delivery. Of the nine countries, China, which has shown the strongest improvement in innovative capacity during the past five years, is expected to continue to outpace other countries and reach near parity with the developed nations of Europe by 2020.

The Medical Technology Innovation Scorecard report polled the nine nations to inquire how attractive they believed the market would be in 2015. The BRIC / developing nations had a more optimistic outlook. View individual country responses to how attractive they believed the market opportunity would be in 2015 here.

Our perspectives

Josh Makower, M.D., Founder & Chief Executive Officer of ExploraMed, shares his views on the future of the medical technology ecosystem.

Compare scores

The interactive graphic above allows you to view the scores and data for each country and to compare any two of the nine countries.

Attractiveness of market commercialization opportunity

Figure 17 from the report plots survey respondents expectations for which countries will become more or less attractive for medical technology commercialization opportunities in 2015.

Emerging economies were expected to become more attractive due to a new and growing consumer class.